$DCOY
Decoy Therapeutics Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$1.20
▲+9.09%+$0.100
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateDecoy Therapeutics Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is DCOY up today? It is at $1.20 (+9.09%), and our scanner flagged it 5 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment DCOY spikes, and full due diligence on DCOY — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $DCOY 5 times in the last 30 days. Create a free account to track $DCOY, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on DCOY from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystDecoy Therapeutics, Inc. Announces a Warrant Inducement Transaction for $3.85 Million in Gross Proceeds Priced At-The-Market under Nasdaq Rules, from an SEC filing. Read it →Latest filingEFFECTRegistration declared effectiveOct 19, 2026 · 10 days agoAcross every filing on file, supply equal to 737% of the tradeable float is in play - 737% has already been sold.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
4,754,150 new shares · About $3.9M in size
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Gauthier Patricia G. Director | Acquired (grant/award) | +2K 0.3% of company | n/a | 2K | n/a | Aug 31, 26 |
Mcvicar William K. Director | Acquired (grant/award) | +3K 0.5% of company | added 100% | 3K | n/a | Aug 31, 26 |
Burleson Tess Director | Acquired (grant/award) | +2K 0.3% of company | added 100% | 2K | n/a | Aug 31, 26 |
Lammers Paul Director | Acquired (grant/award) | +2K 0.3% of company | added 100% | 2K | n/a | Aug 31, 26 |
Hanish Arnold C Director | Acquired (grant/award) | +3K 0.5% of company | added 100% | 3K | n/a | Aug 31, 26 |
Hibner Barbara Louise Officer | Acquired (grant/award) | +4K 0.6% of company | n/a | 4K | n/a | Aug 31, 26 |
Rosenblum Mark J Officer | Acquired (grant/award) | +10K 1.5% of company | added 100% | 11K | n/a | Aug 31, 26 |
Marschel Peter Klaus Officer | Acquired (grant/award) | +4K 0.6% of company | n/a | 4K | n/a | Aug 31, 26 |
Pierce Frederick Ii Officer | Acquired (grant/award) | +33K 5.1% of company | added 100% | 35K | n/a | Aug 31, 26 |
Lieber Jonathan I Director | Acquired (grant/award) | +2K 0.3% of company | added 100% | 2K | n/a | Aug 31, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on DCOY from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
DCOY last traded at $1.20, up 9.09% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Decoy Therapeutics Inc. Common Stock (DCOY) is next expected to report earnings on Friday, November 13, 2026, about 14 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The DCOY Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged DCOY 5 times in the last 30 days.
DCOY (Decoy Therapeutics Inc. Common Stock) trades on XNAS, with a market cap of about $805,878 in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge DCOY for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$DCOY discussion
Sign in to ask a question or join the discussion.